AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Merck has released the first data from a giant study of ...
M2 PRESSWIRE-24 August 2006-www.equityallianceir.com: Merck has released the first data from a giant study of ...(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:25082006
EQUITY ALLIANCE SPOTLIGHTS: Merck & Co. Inc (NYSE:MRK) Current Price (40.46) Volume: 10,788,400 www.equityallianceir.com
Merck's Vioxx Heir Matthew Herper, 08.23.06, 5:25 PM ET
Merck has released the first data from a giant study of Arcoxia, the drug that was designed to be an heir to its withdrawn painkiller Vioxx, and says it still hopes the U.S. Food and Drug Administration will approve the drug, based on the new data..
Merck (nyse: MRK - news - people ) says the study found no more risk to the heart from Arcoxia than with an older drug that is commonly used in Europe. But, as Forbes.com predicted on Monday, critics still see problems with data. (See: " Vioxx, The Sequel.") Still, Merck shares jumped 71 cents, or 1.8%, to $40.46, near their 52-week high.
Vioxx was pulled from the market in September 2004 after a Merck-funded study found that it increased the risk of heart attack and stroke. Angry patients have filed more than 11,000 lawsuits, alleging Merck should have warned them of the drug's risk, potentially costing the drugmaker billions. Arcoxia is being watched because investors want to know if it has any chance of getting approved, and because it could give hints to whether other drugs such as Vioxx--including Pfizer's…
- ARCOXIA Relieved Pain from Acute Gouty Arthritis Comparable to Indomethacin in...
- Press release article from: Business Wire May 7, 2004 700+ words
...acute gouty arthritis demonstrated that ARCOXIA(TM) (etoricoxib) 120 mg once daily...pain and in patients with severe pain. ARCOXIA is Merck & Co. Inc.'s investigational...San Francisco. "In this analysis, ARCOXIA 120 mg once daily provided effective relief...
- ARCOXIA Demonstrated Superior Results Versus Placebo in the Treatment of...
- Press release article from: Business Wire October 28, 2002 700+ words
...BUSINESS WIRE)--Oct. 28, 2002 ARCOXIA Also Showed Superior Treatment Effects...primary efficacy analysis of a new study, ARCOXIA(TM) (etoricoxib) demonstrated superior...the combined group of patients taking ARCOXIA 90 mg or 120 mg once daily demonstrated...
- Investigational Medicine ARCOXIA-TM- Relieved Pain from Acute Gouty Arthritis...
- Press release article from: Business Wire March 20, 2003 700+ words
...acute gouty arthritis demonstrated that ARCOXIA(TM) (etoricoxib) 120 mg once daily...a standard treatment for the disease. ARCOXIA is Merck & Co. Inc.'s investigational...amp; Co., Inc. "In the study, ARCOXIA 120 mg once daily provided effective relief...
- Study showed ARCOXIA improved gastrointestinal tolerability.
- Newspaper article from: Science Letter November 16, 2004 700+ words
...NewsRx.net) -- In a new clinical study, ARCOXIA (etoricoxib) demonstrated significantly fewer...thrombotic cardiovascular events were similar for ARCOXIA and diclofenac sodium. ARCOXIA is Merck & Co., Inc.'s investigational COX...
- CORRECTING and REPLACING ARCOXIA Significantly Reduced the Risk of Upper...
- Press release article from: Business Wire June 11, 2004 700+ words
...graph should read: "In this analysis, ARCOXIA reduced a patient's risk of having an...percent...(sted "In this analysis, ARCOXIA reduced a patient's risk of having an...The corrected release reads: ARCOXIA SIGNIFICANTLY REDUCED THE RISK OF UPPER...
- FDA rejects Merck's Arcoxia: It was a successor to Vioxx, which the firm had...
- Newspaper article from: Philadelphia Inquirer (Philadelphia, PA) April 28, 2007 700+ words
...amp; Co. Inc.'s arthritis drug Arcoxia amid concerns that it could pose some...issued a "nonapprovable" letter for Arcoxia stating that "Merck would need to provide...risk profile for the proposed doses of Arcoxia in order to gain approval." The FDA...
- New Study Showed Investigational Medicine ARCOXIA Had Improved Gastrointestinal...
- Press release article from: Business Wire October 19, 2004 700+ words
WHITEHOUSE STATION, N.J. -- ARCOXIA and Diclofenac Had Similar Rates of Cardiovascular...College of Rheumatology in San Antonio, ARCOXIA(TM) (etoricoxib) demonstrated significantly...cardiovascular events were similar for ARCOXIA and diclofenac sodium. ARCOXIA is Merck...
- Merck Provides Preliminary Analyses of the Completed MEDAL Program for...
- Press release article from: Business Wire August 23, 2006 700+ words
...between the selective COX-2 inhibitor ARCOXIA(TM) and diclofenac, a traditional...confirmed thrombotic CV events between ARCOXIA and diclofenac was 0.95 (95 percent...confirmed thrombotic CV events between ARCOXIA and diclofenac was 1.05 (95 percent...
- New drug for arthritis?: Merck seeking FDA approval for Arcoxia, a chemical...
- Newspaper article from: Newsday (Melville, NY) March 21, 2007 700+ words
...Co. is seeking government approval for Arcoxia, a chemical relative of Vioxx, the drug...Food and Drug Administration approves Arcoxia, Merck could recoup some of those sales...advisory panel will consider approval of Arcoxia for osteoarthritis; it is already sold...
- Arcoxia reduced risk of GI side effects compared with three other NSAIDs.
- Newspaper article from: Pain & Central Nervous System Week July 12, 2004 700+ words
...NewsRx.com & NewsRx.net) -- Arcoxia (etoricoxib) significantly reduced the...League Against Rheumatism (EULAR). Arcoxia is the investigational COX-2 specific...Station, New Jersey. "In this analysis, Arcoxia reduced a patient's risk of having an...
Source: HighBeam Research, Merck has released the first data from a giant study of ...
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
